Address
3222 Phoenixville Pike
Malvern, PA 19355
United States of America (the)
Phone
610 640 4202
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
716
First IPO Date
June 28, 2018
| Name | Title | Pay | Year Born |
| Daniel L. Reuvers | President, Chief Executive Officer & Director | 927,610 | 1963 |
| Steven E. Pfanstiel | Executive Vice President, Treasurer & Chief Financial Officer | 557,223 | 1973 |
| W. Andrew Macan | EVice President, Chief Legal Officer & Corporate Secretary | 652,545 | 1973 |
| Robert Greene | Senior Vice President of Sales | 0 | N/A |
| Cory S. Anderson | SVP & Chief Technology Officer | 0 | N/A |
| Francis X. Brown | Interim Principal Financial & Accounting Officer | 0 | N/A |
| Jeffrey S. Jones | Senior Vice President & Chief of Operations | 0 | 1956 |
| Lisa Metzner-Rosas | Senior Vice President & Chief Marketing Officer | 0 | N/A |
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.